268 records.
Every status attached.
Download a deduplicated registry snapshot across Retatrutide, CagriSema, Cagrilintide, MariTide, Zenagamtide, Enicepatide, Eloralintide, Petrelintide, Survodutide, Mazdutide, Ecnoglutide, Pemvidutide, and VK2735.
Exact intervention searches, deduplicated by NCT ID.
Each tracked program has a bounded list of current and former intervention names. The refresh workflow searches each term through the ClinicalTrials.gov API, unions the responses, deduplicates them by NCT ID, and retains every matching program on combination and master-protocol records.
The historical ALT-801 oncology name collides with Pemvidutide's former development code. Those older oncology records are excluded unless the lead sponsor is Altimmune or the intervention is explicitly named Pemvidutide. Generic mechanism phrases are not searched.
Facility names, investigator names, emails, and phone numbers are omitted. City, state or region, postal code, country, and registry geocoordinates are retained only for site observations individually marked Recruiting. Readers must open the official NCT record for current eligibility and contact information.
13 programs, one registry method.
A record can belong to more than one program when a combination study or master protocol contains multiple tracked interventions. Program totals therefore should not be summed into a unique-study count.
Fields that keep status and location honest.
CSV country and state fields use name:listed:recruiting groups separated by pipes. The recruiting-site column contains a JSON array so city, postal, and coordinate fields remain unambiguous. The JSON download preserves all location fields as nested objects.
- nct_id
- ClinicalTrials.gov identifier for the registry record.
- program_slugs
- Peptide Local pipeline programs matched by exact named-intervention searches. A master protocol or combination study can match more than one program.
- overall_status
- Sponsor-submitted overall study status from ClinicalTrials.gov at the snapshot timestamp.
- status_verified_date
- Month or date when the sponsor last verified the overall status field.
- phase
- Registry phase label. Not applicable is preserved rather than converted into a numbered phase.
- enrollment
- Actual or estimated enrollment as labelled in the registry record.
- primary_completion_date
- Actual or estimated primary completion date, with its type preserved separately.
- last_update_posted
- Date the latest submitted registry update was posted.
- has_results
- Whether ClinicalTrials.gov exposes a posted results module. False does not prove that no result exists elsewhere.
- listed_locations
- Count of facilities retained on the registry record at the snapshot timestamp.
- recruiting_locations
- Count of listed facilities whose individual site status was Recruiting.
- recruiting_sites
- City, state or region, postal code, country, and registry geocoordinates for site observations individually marked Recruiting. Facility and personal contact fields are omitted.
- countries
- Country-level location counts encoded as country:listed:recruiting.
- us_states
- US state-level location counts encoded as state:listed:recruiting.
- source_url
- Direct ClinicalTrials.gov study record.
53 countries represented.
These are registry-listed site observations. They are not unique facilities, legal access findings, approved supply routes, or proof that a study is recruiting in every represented country.
| Country | Study records | Recruiting studies | Listed sites | Recruiting sites | Finder |
|---|---|---|---|---|---|
| United States | 149 | 35 | 4,760 | 1,481 | Filter records → |
| Japan | 42 | 16 | 674 | 334 | Filter records → |
| China | 72 | 22 | 697 | 289 | Filter records → |
| Germany | 69 | 22 | 516 | 211 | Filter records → |
| Poland | 50 | 17 | 620 | 197 | Filter records → |
| Spain | 44 | 17 | 420 | 188 | Filter records → |
| United Kingdom | 43 | 15 | 449 | 171 | Filter records → |
| Argentina | 41 | 14 | 456 | 163 | Filter records → |
| Australia | 51 | 22 | 376 | 159 | Filter records → |
| Canada | 55 | 17 | 547 | 142 | Filter records → |
| Czechia | 27 | 13 | 237 | 122 | Filter records → |
| Brazil | 25 | 10 | 281 | 119 | Filter records → |
| Turkey (Türkiye) | 18 | 11 | 243 | 113 | Filter records → |
| South Korea | 29 | 14 | 246 | 110 | Filter records → |
| Italy | 28 | 12 | 278 | 90 | Filter records → |
| Taiwan | 29 | 14 | 165 | 88 | Filter records → |
| France | 23 | 10 | 201 | 86 | Filter records → |
| Bulgaria | 21 | 8 | 249 | 86 | Filter records → |
| Hungary | 32 | 9 | 261 | 82 | Filter records → |
| Belgium | 24 | 11 | 154 | 68 | Filter records → |
Cite the landing page so the boundary travels.
Suggested citation: Peptide Local Editorial Desk. “Peptide and Weight-Loss Drug Clinical Trial Registry.” Version 2026-07-24. https://peptidelocal.com/data/peptide-clinical-trials.
ClinicalTrials.gov data timestamp: July 24, 2026 at 9:00 AM UTC. The registry can change after this release. Use the exact NCT record for any current enrollment decision.
Read the official API documentation ↗Read the editorial method →Submit a correction →